These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8842617)

  • 1. Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?
    Kordonouri O; Danne T; Weber B
    Diabetes Care; 1996 Aug; 19(8):901-2. PubMed ID: 8842617
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
    Trofimenko EV; Zlobina EV; Lebedev NV; Martynova MI; Piliutik VF; Shchegol'kova TS; Zlobina EN; Dedov II
    Probl Endokrinol (Mosk); 1994; 40(2):18-21. PubMed ID: 8197083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function.
    Novak EJ; Ortqvist E; Nord E; Edwall L; Hampe CS; Bekris L; Persson BE; Lernmark A
    Diabetes Care; 2000 Jul; 23(7):1019-21. PubMed ID: 10895858
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.
    Tuomilehto J; Zimmet P; Mackay IR; Koskela P; Vidgren G; Toivanen L; Tuomilehto-Wolf E; Kohtamäki K; Stengård J; Rowley MJ
    Lancet; 1994 Jun; 343(8910):1383-5. PubMed ID: 7910881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
    Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in relation to residual insulin secretion in children with IDDM.
    Ludvigsson J; Hellström S
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM.
    Yokota I; Shirakawa N; Shima K; Matsuda J; Naito E; Ito M; Kuroda Y
    Diabetes Care; 1996 Jan; 19(1):74-5. PubMed ID: 8720540
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
    Imagawa A; Hanafusa T; Miyagawa J; Matsuzawa Y
    N Engl J Med; 2000 Feb; 342(5):301-7. PubMed ID: 10655528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes.
    Gottsäter A; Landin-Olsson M; Lernmark A; Fernlund P; Sundkvist G; Hagopian WA
    Diabetes Res Clin Pract; 1995 Feb; 27(2):133-40. PubMed ID: 7607051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
    Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.